Rigetti Announces Order for a 108-Qubit Quantum Computer from India’s Centre for Development of Advanced Computing (C-DAC)

(NASDAQ:RGTI),(NASDAQ:RGTIW), BERKELEY, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — Rigetti Computing India P L, a wholly owned subsidiary of Rigetti Computing, Inc. (Nasdaq: RGTI) (“Rigetti” or the “Company”), a pioneer in full-stack quantum-classical computing, today announced that it has received an $8.4 million purchase order to deliver a 108-qubit quantum computer to the Centre for […]

LM Funding America Adds Additional 35 PH/s with Energization of Second Oklahoma Immersion Unit

(NASDAQ:LMFA), TAMPA, Fla., Jan. 20, 2026 (GLOBE NEWSWIRE) — LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today announced that it has successfully energized the second BC40 Elite immersion cooled Foghashing unit at its Oklahoma site. This unit, powering an additional 160 next-generation Bitmain S21 immersion

LaunchDarkly Expands Leadership Team in Response to Accelerated Growth and AI Tailwinds

OAKLAND, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — LaunchDarkly, the comprehensive feature management platform, today announced the appointment of Cameron Etezadi as Chief Technology Officer and Robert O'Donovan as Chief Financial Officer, along with the return of Jonathan Nolen as SVP of Product. These additions to the executive team come as the company is nearing

CareCloud Announces Preferred Stock Dividend Payments

(NasdaqGM:CCLD),(NasdaqGM:CCLDP),(NasdaqGM:CCLDO), SOMERSET, N.J., Jan. 20, 2026 (GLOBE NEWSWIRE) — CareCloud, Inc. (“CareCloud” or the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the “Board”) has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable

Catheter Precision Received new VIVO Purchase Order from Leading Hospital in Slovenia

(NYSE MKT: VTAK), FORT MILL, S.C., Jan. 20, 2026 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced receipt of a VIVO purchase order from University Clinical Center Ljubljana, a leading hospital in Slovenia. This expands

Cordia to Supply Renewable District Cooling to ASU Health Headquarters in Downtown Phoenix

Phoenix, AZ, Jan. 20, 2026 (GLOBE NEWSWIRE) — Cordia, a leading provider of energy solutions, announced today that it has signed a 20-year agreement to provide chilled water service to the new Arizona State University (ASU) Health headquarters at the Phoenix Bioscience Core (PBC). The building will be cooled from Cordia's Plant 4, a new

NVTC Announces Finalists for the 2026 Data Center Awards

Finalists advancing Northern Virginia’s leadership in AI infrastructure, economic impact, and digital innovation The Northern Virginia Technology Council (NVTC), the region’s leading technology trade association, today announced the finalists for the seventh annual NVTC Data Center Awards, recognizing the companies and leaders shaping the future of digital infrastructure and the global AI-driven economy. Northern Virginia

Nasus Pharma Announces Positive Interim Results from Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder

(NYSE:NSRX), Interim results indicate NS002 demonstrated significantly faster absorption and higher peak epinephrine levels compared to EpiPen(R) 91% of study participants achieved the 100 pg/ml plasma threshold at 5 minutes with NS002 compared to 67% with EpiPen(R) NS002 was well-tolerated with no serious adverse events reported, and a pharmacodynamic response comparable to EpiPen(R) Full Phase

Ouro Medicines Receives U.S. FDA Fast Track Designation for Gamgertamig in Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

Gamgertamig previously received Orphan Drug Designation (ODD) for development in immune thrombocytopenia and autoimmune hemolytic anemia Ouro Medicines, a clinical stage biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated diseases, today announced that gamgertamig (OM336), the company’s BCMAxCD3 T cell engager antibody investigational candidate, has been granted U.S. Food and Drug

THORNE DEBUTS ‘NOW I KNOW’ – A NATIONWIDE CAMPAIGN BUILT ON PROVEN SCIENCE AND CONFIDENT CHOICES

Omni-channel rollout empowers consumers to cut through wellness noise and make more confident, science-backed decisions Thorne, the leader in science-backed health and wellness solutions, today unveiled its nationwide, omni-channel Now I Know campaign, designed to help consumers navigate modern wellness with confidence, clarity, and evidence they can trust. Today’s wellness landscape is marked by an

Scroll to Top